Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Shares Issued (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Shares Issued for 3 consecutive years, with -$448000.0 as the latest value for Q4 2025.

  • Quarterly Shares Issued changed N/A to -$448000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $39000.0 through Dec 2025, down 99.92% year-over-year, with the annual reading at $39000.0 for FY2025, 99.92% down from the prior year.
  • Shares Issued for Q4 2025 was -$448000.0 at Mereo BioPharma, down from $487000.0 in the prior quarter.
  • The five-year high for Shares Issued was $47.0 million in Q2 2024, with the low at -$448000.0 in Q4 2025.
  • Average Shares Issued over 3 years is $14.6 million, with a median of $6.0 million recorded in 2023.